To further investigate the possible divergent roles of tumor-infiltrating CD4+ and CD8+ T cells in breast cancer development, we performed univariate Cox proportional hazard regression analyses of the relationships between CD4+ and CD8+ T cell levels, other prognostic clinicopathological factors and clinical outcomes in breast cancer patients. The gene discussed is CD8A; the disease is breast cancer.